secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0000950170-24-093114
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q2 revenue up 20% to $312M; raises FY2024 guidance on strong margins
-------------------------------------------------------------------------------

- Revenue $312.3M (+20% YoY); net loss narrowed to $23.3M from $45.5M; Adjusted EBITDA $28.6M (+103%).
- Center Margin improved to 31.3% of revenue (28.1% prior year); clinician base up 14% to 6,984.
- FY2024 guidance raised: revenue $1.2B-$1.242B, Adjusted EBITDA $90M-$100M; expects positive free cash flow.
- Q3 2024 guidance: revenue $290M-$310M, Adjusted EBITDA $15M-$21M.
- Cash $87M, net debt $279.5M; operating cash flow $44.1M in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024093114/0000950170-24-093114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024093114/lfst-20240808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-093114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer